Dino Otranto

CEO

6 past transactions

Electric Hydrogen

Series C in 2023
Electric Hydrogen is a company focused on developing low-cost, high-efficiency, fossil-free hydrogen systems aimed at decarbonizing industrial sectors such as ammonia and steel production, which are significant contributors to global greenhouse gas emissions. By rethinking electrolysis, Electric Hydrogen seeks to make clean hydrogen competitive with traditional, fossil-fuel-based hydrogen in terms of cost and scalability. The company's advanced PEM technology utilizes low-cost renewable electricity to produce clean hydrogen gas, thereby helping industries reduce their reliance on fossil fuels and minimize pollution. With a leadership team experienced in transformative clean energy companies, Electric Hydrogen is positioned to address current challenges in efficiency and cost, contributing to the goal of a zero-emission industrial sector in the near future.

Austal

Post in 2022
Austal is a shipbuilding platform that designs, construct, and support revolutionary defense and commercial vessels.

Williams Advanced Engineering

Acquisition in 2022
Williams Advanced Engineering is a technology and engineering services business. The company provides world-class technical innovation, engineering, testing, and manufacturing services to deliver energy-efficient performance to customers.

High yield Energy Technologies

Acquisition in 2021
HyET group create technologies that enable commercially viable, large scale access to decentral renewable energy sources. The primary objective of the HyET group is to develop a sustainable and profitable business based on the above objective.

Nullagine iron ore project

Acquisition in 2016
Nullagine mine was in production for five years before weak iron ore prices forced it to be shuttered in December last year.

Coridon

Series A in 2010
Coridon is a privately held company based in Brisbane, Australia, founded in 2000. The company specializes in developing DNA therapies aimed at preventing and treating viral infections, including Herpesvirus and Hepatitis C, as well as therapeutic vaccines for cancer treatment. Coridon's focus on DNA vaccines addresses both acute and chronic diseases, providing innovative solutions for patients in need of effective medicinal interventions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.